C57BL/6 腹膜巨细胞外体改善RAW264.7细胞的抗莱什曼功能
Hadis Gandomkar1, Mostafa Changaei1, Mir Mohammadreza Hosseini2
1Department of Immunology, Factually of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Parasite immunology
|October 15, 2024
概括
来自巨细胞的外体显示出对抗莱什曼病的潜力. 这些外体细胞增强了免疫细胞功能,如细胞分裂,并减少了寄生虫负载,提供了一种有前途的新策略来对抗这个被忽视的热带疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 寄生虫学的寄生虫学
- 细胞生物学 细胞生物学
背景情况:
- 莱什曼病是一个全球性的健康问题,有效的治疗方法有限,没有可用的疫苗.
- 外体,纳米大小的囊泡,已经成为治疗各种疾病的有希望的治疗剂,包括传染病.
研究的目的:
- 调查外体体,甲胺 (PM) 和它们的组合对莱什马尼亚主要感染RAW264.7细胞的抗寄生虫作用.
- 评估这些治疗对巨细胞功能的影响,如细胞,细胞,氧化 (NO),活性氧物种 (ROS) 生产,酶活性和细胞内寄生虫负担.
主要方法:
- 从C57BL/6腹巨细胞中分离出外体.
- RAW264.7细胞,感染或不感染Leishmania大,被治疗外体,PM,或一个组合.
- 测量了关键的免疫参数,包括细胞化,细胞化,NO,ROS,阿根酶活性和寄生虫数量.
主要成果:
- 外体细胞显著增强了受感染和未受感染细胞中的细胞化,细胞化,NO和ROS产生 (P <0.05).
- 外体导致阿根酶活性显著降低 (P < 0.05).
- 用外体的治疗导致细胞内Leishmania主要寄生虫数量显著下降 (P <0.05).
结论:
- 巨细胞衍生的外体体在体外表现出显著的抗寄生虫活性,对抗大莱什曼尼亚.
- 外体细胞增强了关键的巨细胞功能,这对于对抗莱什曼病至关重要.
- 这些发现强调了外体作为莱什曼病的潜在治疗策略,需要进一步研究.
相关概念视频
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...